Ping-Ting Gao

Ping-Ting Gao

Auto-generated profile, based on publicly available information

Ping-Ting Gao

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
PGPingting Gao
Pingting Gao
SLShengli Lin
Shengli Lin
MCMingyan Cai
Mingyan Cai
YZYan Zhu
Yan Zhu
YSYanqun Song
Yanqun Song
PZPinghong Zhou
Pinghong Zhou
5‐Hydroxymethylcytosine (5hmC) is a DNA modification that is generated by the oxidation of 5‐methylcytosine (5mC) in a reaction catalyzed by the ten‐eleven translocation (TET) family enzymes. It tends to mark gene activation and affects a spectrum of developmental and disease‐related biological processes. In this manuscript, we present a 5hmC selective chemical labelling technology (hmC‐Seal) to capture and sequence 5hmC‐containing DNA fragments with low input. We tested 10 tumour/adjacent colon cancer tissues and 10 tumour/healthy plasma samples. Furthermore, we tested if this methodology could generate the 5hmC differential genes among cancer patients, healthy controls and precancerous adenoma patients from plasma. Robust cancer‐specific epigenetic signatures were identified for colon cancers. The results show that 5hmC is mainly distributed in gene active regions. The results also indicate the potential application of 5hmC change signals in early stage of colon cancer, even show potential in the diagnosis of precancerous adenoma. We demonstrated the robustness of the 5hmC‐Seal method in tissue and cell‐free DNA (cfDNA) as potential biomarkers. Moreover, this study provides the potential value and feasibility of 5hmC‐Seal approach on colorectal cancer (CRC) early detection. We believe this strategy could be an effective liquid biopsy‐based diagnosis and a potential prognosis method for colon cancer using cfDNA.


30 July 2025 in Clinical Endoscopy
Verified
Journal Article
Open access
PGPingting Gao
Pingting Gao
JYJia Yu
Jia Yu
MCMingyan Cai
Mingyan Cai
LMLili Ma
Lili Ma
QLQuanlin Li
Quanlin Li
PZPinghong Zhou
Pinghong Zhou
Natural orifice transluminal endoscopic surgery (NOTES) represents a revolutionary advancement in minimally invasive surgery, eliminating the need for external incisions and offering faster recovery and improved aesthetics. Endoscopic transgastric cholecystectomy (ETGC), a NOTES-based procedure, stands out for its potential to revolutionize gallbladder removal by offering a truly scarless alternative to traditional laparoscopic cholecystectomy (LC). This review explores the historical development of cholecystectomy, evolution of NOTES, and emergence of ETGC as a feasible alternative to LC. We highlight the technical refinements that have enabled ETGC, including innovations in full-thickness resection and suturing techniques, and discuss challenges such as visibility, orientation, and wound closure. Finally, we examine the role of robotic platforms in enhancing precision and expanding clinical applications by positioning ETGC as a transformative technique in the era of minimally invasive surgery.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
PGPing-Ting Gao
Ping-Ting Gao
SLSheng-Li Lin
Sheng-Li Lin
PFPei-Yao Fu
Pei-Yao Fu
QLQuan-Lin Li
Quan-Lin Li
MCMingyan Cai
Mingyan Cai
PZPinghong Zhou
Pinghong Zhou
Objective: To evaluate the effectiveness and safety of endoscopic resection and suturing methods for the treatment of non-ampullary duodenal submucosal tumors (NAD-SMTs). Design: This retrospective observational study included patients with NAD-SMTs underwent endoscopic resection at Zhongshan Hospital, Fudan University between June 2017 and December 2020. Data on patient characteristics, treatment information and follow-up results were collected. The association of clinicopathologic characteristics with different suturing methods and adverse events were analyzed. Results: Among 128 patients, 26 patients underwent endoscopic mucosal resection (EMR), 64 patients underwent endoscopic submucosal excavation (ESE) and 38 patients underwent endoscopic full-thickness resection (EFTR). For non-full-thickness lesions, both EMR and ESE are applicable. But for tumors located in the bulb or descending part, ESE are more likely to be chosen and gastric tube drainage is more recommended after ESE. And satisfactory suture is of vital importance in all endoscopic resection for NAD-SMTs. For lesions that are not full-thickness undergoing EMR or ESE, metallic clips are the first to choose. For those who underwent full-thickness resection, especially when those postoperative pathology turned out to be gastrointestinal stromal tumors (GIST), Brunner’s tumor or lipoma, we were more likely to choose purse-string suture to close the wound. Purse-string suture took longer operation time than metallic clips closure. Eleven patients had complications. SMTs with large diameters(≥2cm), located in the descending part of duodenum, involving forth layer of duodenal wall, those did EFTR and GIST had significant impact on the occurrence of adverse events. Conclusions: Endoscopic resection of NAD-SMTs is effective. However, it is associated with high incidence rate of complications owing to the duodenal anatomical peculiarities. Preoperative diagnosis is quite important. Choice of effective treating modality and way of suturing are of necessity to prevent adverse effects. Given the increased frequency of severe complications during or following duodenal endoscopic resection, this procedure should be rather reserved for experienced endoscopists. Funding Information: This study was supported by the grant from the National Natural Science Foundation of China (81902394) & Shanghai Dawnlight program (20CG07) & Excellent Young Scholar Foundation of Zhongshan Hospital (2021ZSYQ08). Declaration of Interests: The authors disclose no conflicts. Ethics Approval Statement: This study was approved by the Ethics Committee of Zhongshan Hospital (B2021-558). The informed consent was waived due to retrospective nature.